Paper Details

Paper Title

Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.

Paper Journal Title

Crit Care Med

Paper Citation Count

163

Paper Publication Year

2018

Bio Mention

Acute kidney injury, Angiotensin II, PATIENTS, Patients, Vasodilatory Shock, acute kidney injury, angiotensin II, patients, vasodilatory shock

Mesh Descriptor

Acute Kidney Injury, Aged, Angiotensin II, Humans, Infusions, Intravenous, Middle Aged, Renal Replacement Therapy, Shock, Treatment Outcome

Author Name	Affiliation
James A Tumlin	University of Tennessee College of Medicine
Raghavan Murugan	and Clinical and Translational Science, Center for Critical Care Nephrology, University of Pittsburgh School of Medicine
Adam M Deane	Royal Melbourne Hospital, University of Melbourne
Marlies Ostermann	King's College London, Guy's & St Thomas' Hospital
William W Busse	Emory University
Kealy R Ham	University of Minnesota Medical School.
Kianoush B Kashani	Mayo Clinic
Harold M Szerlip	Baylor University Medical Center
John R Prowle	The Royal London Hospital
Azra Bihorac	University of Florida
Azra Bihorac	University of Florida
Kevin W Finkel	University of Texas Health Science Center at Houston
Alexander Zarbock	University Hospital Munster
Lui G Forni	University of Surrey & Critical Care Unit, Royal Surrey County Hospital
Shannan J Lynch	La Jolla Pharmaceutical Company.
Jeff Jensen	La Jolla Pharmaceutical Company.
Stewart Kroll	La Jolla Pharmaceutical Company.
Lakhmir S Chawla	La Jolla Pharmaceutical Company.
George F Tidmarsh	La Jolla Pharmaceutical Company.
Rinaldo Bellomo	The University of Melbourne, Australia Austin Hospital, Royal Melbourne Hospital

Column Actions